ConductScience.org, home

Trial · NCT01100944

Participant flow27

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Dose Escalation Phase 1 Dose Level 1STARTEDBelinostat 250mg/m(2) and Chemotherapy6
Dose Escalation Phase 1 Dose Level 1STARTEDBelinostat 500mg/m(2) and Chemotherapy0
Dose Escalation Phase 1 Dose Level 1STARTEDBelinostat and Chemotherapy at the Maximum Tolerated Dose(MTD)0
Dose Escalation Phase 1 Dose Level 1COMPLETEDBelinostat 250mg/m(2) and Chemotherapy2
Dose Escalation Phase 1 Dose Level 1COMPLETEDBelinostat 500mg/m(2) and Chemotherapy0
Dose Escalation Phase 1 Dose Level 1COMPLETEDBelinostat and Chemotherapy at the Maximum Tolerated Dose(MTD)0
Dose Escalation Phase 1 Dose Level 1NOT COMPLETEDBelinostat 250mg/m(2) and Chemotherapy4
Dose Escalation Phase 1 Dose Level 1NOT COMPLETEDBelinostat 500mg/m(2) and Chemotherapy0
Dose Escalation Phase 1 Dose Level 1NOT COMPLETEDBelinostat and Chemotherapy at the Maximum Tolerated Dose(MTD)0
Dose Escalation Phase 1 Dose Level 2STARTEDBelinostat 250mg/m(2) and Chemotherapy0
Dose Escalation Phase 1 Dose Level 2STARTEDBelinostat 500mg/m(2) and Chemotherapy2
Dose Escalation Phase 1 Dose Level 2STARTEDBelinostat and Chemotherapy at the Maximum Tolerated Dose(MTD)0
Dose Escalation Phase 1 Dose Level 2COMPLETEDBelinostat 250mg/m(2) and Chemotherapy0
Dose Escalation Phase 1 Dose Level 2COMPLETEDBelinostat 500mg/m(2) and Chemotherapy0
Dose Escalation Phase 1 Dose Level 2COMPLETEDBelinostat and Chemotherapy at the Maximum Tolerated Dose(MTD)0
Dose Escalation Phase 1 Dose Level 2NOT COMPLETEDBelinostat 250mg/m(2) and Chemotherapy0
Dose Escalation Phase 1 Dose Level 2NOT COMPLETEDBelinostat 500mg/m(2) and Chemotherapy2
Dose Escalation Phase 1 Dose Level 2NOT COMPLETEDBelinostat and Chemotherapy at the Maximum Tolerated Dose(MTD)0
Expansion Phase - Phase 2STARTEDBelinostat 250mg/m(2) and Chemotherapy0
Expansion Phase - Phase 2STARTEDBelinostat 500mg/m(2) and Chemotherapy0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01100944/flow